Dieser Abschnitt ist nur in englischer Sprache verfügbar.

 – Financial reporting – Consolidated statement of changes in equity

Consolidated statement of changes in equity

January 1 – June 30

 

 

 

 

Attributable to shareholders of Sulzer Ltd

 

 

 

 

millions of CHF

 

Notes

 

Share capital

 

Retained earnings

 

Treasury shares

 

Cash flow hedge reserve

 

Currency translation adjustment

 

Total

 

Non-controlling interests

 

Total equity

Equity as of January 1, 2022

 

 

 

0.3

 

1’967.7

 

–51.0

 

3.3

 

–646.5

 

1’273.8

 

5.5

 

1’279.3

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

–48.3

 

 

 

 

 

 

 

–48.3

 

–0.5

 

–48.8

- Cash flow hedges, net of tax

 

 

 

 

 

 

–2.8

 

 

–2.8

 

 

–2.8

- Remeasurements of defined benefit plans, net of tax

 

 

 

 

–107.0

 

 

 

 

–107.0

 

 

–107.0

- Equity investments at FVOCI – net change in fair value, net of tax

 

 

 

 

–12.0

 

 

 

 

–12.0

 

 

–12.0

- Currency translation differences

 

 

 

 

 

 

 

13.5

 

13.5

 

0.2

 

13.7

Other comprehensive income

 

 

 

 

–119.0

 

 

–2.8

 

13.5

 

–108.3

 

0.2

 

–108.1

Total comprehensive income for the period

 

 

 

 

–167.3

 

 

–2.8

 

13.5

 

–156.6

 

–0.3

 

–156.9

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contribution from medmix

 

10

 

 

0.4

 

 

 

 

0.4

 

 

 

0.4

Transaction costs

 

10

 

 

–0.7

 

 

 

 

–0.7

 

 

 

–0.7

Allocation of treasury shares to share plan participants

 

 

 

 

–27.0

 

27.0

 

 

 

 

 

 

Purchase of treasury shares

 

 

 

 

 

–10.8

 

 

 

–10.8

 

 

 

–10.8

Share-based payments

 

 

 

 

7.2

 

 

 

 

7.2

 

 

 

7.2

Dividends

 

10

 

 

–118.7

 

 

 

 

–118.7

 

–1.1

 

–119.8

Equity as of June 30, 2022

 

 

 

0.3

 

1’661.8

 

–34.9

 

0.6

 

–633.1

 

994.7

 

4.1

 

998.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2023

 

 

 

0.3

 

1’777.7

 

–42.9

 

–4.1

 

–706.7

 

1’024.3

 

4.4

 

1’028.6

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

103.9

 

 

 

 

 

 

 

103.9

 

0.3

 

104.3

- Cash flow hedges, net of tax

 

 

 

 

 

 

9.7

 

 

9.7

 

 

9.7

- Remeasurements of defined benefit plans, net of tax

 

 

 

 

9.4

 

 

 

 

9.4

 

 

9.4

- Equity investments at FVOCI – net change in fair value, net of tax

 

 

 

 

2.4

 

 

 

 

2.4

 

 

2.4

- Currency translation differences

 

 

 

 

 

 

 

–66.6

 

–66.6

 

–0.4

 

–67.1

Other comprehensive income

 

 

 

 

11.8

 

 

9.7

 

–66.6

 

–45.1

 

–0.4

 

–45.6

Total comprehensive income for the period

 

 

 

 

115.8

 

 

9.7

 

–66.6

 

58.8

 

–0.1

 

58.7

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition of non-controlling interests without a change in control

 

4

 

 

–22.4

 

 

 

0.0

 

–22.4

 

–0.4

 

–22.8

Contribution from medmix

 

10

 

 

0.3

 

 

 

 

0.3

 

 

 

0.3

Allocation of treasury shares to share plan participants

 

 

 

 

–26.3

 

26.3

 

 

 

 

 

 

Purchase of treasury shares

 

 

 

 

 

–9.4

 

 

 

–9.4

 

 

 

–9.4

Share-based payments

 

 

 

 

6.1

 

 

 

 

6.1

 

 

 

6.1

Dividends

 

10

 

 

–118.9

 

 

 

 

–118.9

 

–0.1

 

–119.0

Equity as of June 30, 2023

 

 

 

0.3

 

1’732.2

 

–25.9

 

5.6

 

–773.4

 

938.8

 

3.8

 

942.6